Range Low Price High Price Comment
30 days $123.08 $141.99 Tuesday, 30th Apr 2024 DXCM stock ended at $127.39. This is 1.26% more than the trading day before Monday, 29th Apr 2024. During the day the stock fluctuated 2.28% from a day low at $125.78 to a day high of $128.65.
90 days $113.05 $142.00
52 weeks $74.75 $142.00

Historical DexCom prices

Date Open High Low Close Volume
Apr 30, 2024 $126.18 $128.65 $125.78 $127.39 2 985 108
Apr 29, 2024 $125.15 $128.51 $123.08 $125.81 3 767 937
Apr 26, 2024 $132.48 $138.81 $124.08 $124.34 8 547 988
Apr 25, 2024 $138.91 $139.24 $134.45 $138.01 4 062 431
Apr 24, 2024 $132.79 $138.50 $132.48 $137.87 3 227 944
Apr 23, 2024 $131.47 $135.31 $131.00 $134.00 2 005 486
Apr 22, 2024 $131.26 $132.36 $129.74 $131.52 2 093 424
Apr 19, 2024 $134.64 $135.06 $129.18 $130.71 2 847 614
Apr 18, 2024 $134.36 $135.98 $133.58 $134.30 2 114 880
Apr 17, 2024 $136.07 $136.64 $132.88 $133.86 3 204 071
Apr 16, 2024 $135.29 $137.83 $133.22 $136.52 3 021 144
Apr 15, 2024 $137.81 $138.02 $134.50 $134.56 2 513 697
Apr 12, 2024 $138.02 $138.77 $134.28 $136.14 2 373 335
Apr 11, 2024 $140.10 $141.25 $138.19 $139.62 2 057 556
Apr 10, 2024 $138.81 $140.63 $137.42 $140.32 1 795 877
Apr 09, 2024 $140.78 $141.99 $138.53 $140.45 2 767 648
Apr 08, 2024 $139.53 $140.91 $137.47 $139.94 2 279 184
Apr 05, 2024 $133.13 $139.11 $131.74 $138.93 2 373 260
Apr 04, 2024 $139.56 $139.71 $133.23 $133.34 2 637 724
Apr 03, 2024 $136.73 $139.96 $136.59 $138.51 1 627 578
Apr 02, 2024 $136.33 $137.99 $135.21 $136.65 2 331 021
Apr 01, 2024 $138.79 $139.62 $136.98 $137.94 1 767 689
Mar 28, 2024 $139.98 $140.80 $138.52 $138.70 2 473 241
Mar 27, 2024 $141.55 $141.87 $138.12 $139.48 2 014 792
Mar 26, 2024 $140.69 $142.00 $138.50 $139.93 3 057 402
Click to get the best stock tips daily for free!

About DexCom

DexCom DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to i... DXCM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT